Symbol="MRKR"
AssetType="Common Stock"
Name="Marker Therapeutics Inc"
Description="Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, is dedicated to the development and commercialization of various T-cell-based immunotherapies and peptide-based vaccines for the treatment of hematologic malignancies and solid tumor indications. The company is headquartered in Houston, Texas."
CIK="1094038"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="50 N LAURA STREET, SUITE 2500, JACKSONVILLE, FL, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="49772300"
EBITDA="-24194024"
PERatio="None"
PEGRatio="None"
BookValue="2.163"
DividendPerShare="0"
DividendYield="0"
EPS="-3.03"
RevenuePerShareTTM="1.081"
ProfitMargin="-1.429"
OperatingMarginTTM="-2.967"
ReturnOnAssetsTTM="-0.462"
ReturnOnEquityTTM="-1.158"
RevenueTTM="9255700"
GrossProfitTTM="-17125779"
DilutedEPSTTM="-3.03"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.035"
AnalystTargetPrice="40"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="3.593"
PriceToBookRatio="1.134"
EVToRevenue="3.641"
EVToEBITDA="-0.472"
Beta="1.219"
num_52WeekHigh="9.68"
num_52WeekLow="0.671"
num_50DayMovingAverage="5.27"
num_200DayMovingAverage="2.969"
SharesOutstanding="8809300"
DividendDate="2016-09-16"
ExDividendDate="None"
symbol="MRKR"
open="5.58"
high="5.79"
low="5.40"
price="5.54"
volume="51616.00"
latest_trading_day="2023-08-28"
previous_close="5.65"
change="-0.11"
change_percent="-1.9469%"
aroon_positive_momentum_days="57"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="57"
Volume_recent_avg="605701"
Change_recent_avg="0.05"
Delta_recent_avg="0.49"
Variance_recent_avg="0.25"
Change_ratio_recent_avg="0.98"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="57"
Aroon_momentum_negative="43"
image_negative_thumbnail_id_1="1091"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0124.jpeg"
image_negative_thumbnail_id_2="1088"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0121.jpeg"
image_neutral_thumbnail_id_1="546"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0053.jpeg"
image_neutral_thumbnail_id_2="528"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0071.jpeg"
image_positive_thumbnail_id_1="989"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0151.jpeg"
image_positive_thumbnail_id_2="956"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0118.jpeg"
image_professor_thumbnail_id_1="1179"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
image_professor_thumbnail_id_2="1191"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0025.jpeg"
